These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 26397099)

  • 1. Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.
    Sehl ME; Shimada M; Landeros A; Lange K; Wicha MS
    PLoS One; 2015; 10(9):e0135797. PubMed ID: 26397099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer stem cells, EMT and therapeutic targets.
    Kotiyal S; Bhattacharya S
    Biochem Biophys Res Commun; 2014 Oct; 453(1):112-6. PubMed ID: 25261721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment.
    Tomellini E; Touil Y; Lagadec C; Julien S; Ostyn P; Ziental-Gelus N; Meignan S; Lengrand J; Adriaenssens E; Polakowska R; Le Bourhis X
    Stem Cells; 2015 Feb; 33(2):342-53. PubMed ID: 25286822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications.
    Zeng X; Liu C; Yao J; Wan H; Wan G; Li Y; Chen N
    Pharmacol Res; 2021 Jan; 163():105320. PubMed ID: 33271295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Breast Cancer Stem Cells.
    Zhang L; Chen W; Liu S; Chen C
    Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining duration of HER2-targeted therapy using stem cell extinction models.
    Riley L; Zhou H; Lange K; Sinsheimer JS; Sehl ME
    PLoS One; 2012; 7(12):e46613. PubMed ID: 23284608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation.
    Choi HS; Kim JH; Kim SL; Lee DS
    Cells; 2019 Aug; 8(9):. PubMed ID: 31480284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity.
    Strietz J; Stepputtis SS; Follo M; Bronsert P; Stickeler E; Maurer J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMT in breast cancer stem cell generation.
    Ansieau S
    Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
    El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
    Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines driving breast cancer stemness.
    Chin AR; Wang SE
    Mol Cell Endocrinol; 2014 Jan; 382(1):598-602. PubMed ID: 23562748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.